We also show that the disruption of these mutual interactions through the targeting of HIF-1α or its regulatory pathways exerts anti-tumor effects by acting at both the leukemic cell- and SC-levels, possibly representing an appealing strategy for overcoming microenvironment-mediated tumor support. This evidence concerns the gene HIF1A and neoplasm.